Age-Specific Effectiveness of an Oil-in-Water Adjuvanted Pandemic (H1N1) 2009 Vaccine Against Confirmed Infection in High Risk Groups in England

Lignende værker

• Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England
  af: Yung, Chee-Fu, et al.
  Udgivet: (2013)
• Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England
  af: Winstone, Anne Marie, et al.
  Udgivet: (2014)
• Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation
  af: Baguelin, Marc, et al.
  Udgivet: (2011)
• Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England
  af: Stowe, Julia, et al.
  Udgivet: (2016)
• Mortality Attributable to Influenza in England and Wales Prior to, during and after the 2009 Pandemic
  af: Green, Helen K., et al.
  Udgivet: (2013)